Analysis of duration of response: A problem of oncology trials
- 1 March 1988
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 9 (1) , 11-18
- https://doi.org/10.1016/0197-2456(88)90004-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisoneCancer, 1985
- Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariatesBiometrika, 1984
- Reporting Results From Chemotherapy TrialsPublished by American Medical Association (AMA) ,1984
- Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group BBlood, 1984
- A non‐parametric graphical representation of the relationship between survival and the occurrence of an event: Application to responder versus non‐responder biasStatistics in Medicine, 1984
- Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trialsControlled Clinical Trials, 1983
- An uncontrolled clinical trial—treatment response or spontaneous improvement?Controlled Clinical Trials, 1982
- Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocytic leukemia: A randomized collaborative studyMedical and Pediatric Oncology, 1978
- Randomized clinical trial of cystosine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemiaCancer, 1977
- Evaluation of Response-Time Data Involving Transient States: An Illustration Using Heart-Transplant DataJournal of the American Statistical Association, 1974